Present status of human papillomavirus vaccine development and implementation

R Herrero, P González, LE Markowitz - The Lancet Oncology, 2015 - thelancet.com
Oncogenic human papillomavirus (HPV) infection is the cause of nearly all cervical cancers
and a proportion of other anogenital and oropharyngeal cancers. A bivalent vaccine …
被引用次数：234 相关文章

Present status of human papillomavirus vaccine development and implementation

R Herrero, P González, LE Markowitz - The Lancet Oncology, 2015 - infona.pl
Oncogenic human papillomavirus (HPV) infection is the cause of nearly all cervical cancers
and a proportion of other anogenital and oropharyngeal cancers. A bivalent vaccine …

Present status of human papillomavirus vaccine development and implementation

R Herrero, P González… - The Lancet …, 2015 - pubmed.ncbi.nlm.nih.gov
Oncogenic human papillomavirus (HPV) infection is the cause of nearly all cervical cancers
and a proportion of other anogenital and oropharyngeal cancers. A bivalent vaccine …

Present status of human papillomavirus vaccine development and implementation.

R Herrero, P González, LE Markowitz - 2015 - cabidigitallibrary.org
Oncogenic human papillomavirus (HPV) infection is the cause of nearly all cervical cancers
and a proportion of other anogenital and oropharyngeal cancers. A bivalent vaccine …

[引用][C] Present status of human papillomavirus vaccine development and implementation

R Herrero, P González, LE Markowitz - The Lancet Oncology, 2015 - cir.nii.ac.jp
Present status of human papillomavirus vaccine development and implementation | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Present status of human papillomavirus vaccine development and implementation

R Herrero, P González, LE Markowitz - The Lancet Oncology, 2015 - Elsevier
Oncogenic human papillomavirus (HPV) infection is the cause of nearly all cervical cancers
and a proportion of other anogenital and oropharyngeal cancers. A bivalent vaccine …

Present status of human papillomavirus vaccine development and implementation.

R Herrero, P González, LE Markowitz - The Lancet. Oncology, 2015 - europepmc.org
Oncogenic human papillomavirus (HPV) infection is the cause of nearly all cervical cancers
and a proportion of other anogenital and oropharyngeal cancers. A bivalent vaccine …

[引用][C] Present status of human papillomavirus vaccine development and implementation

R Herrero, P González, LE Markowitz - Lancet Oncology, 2015 - Elsevier Limited